Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FFAR1 | O14842 | 19/20 | 0.51 |
| ▸ | PPARD | Q03181 | 3/20 | 0.50 |
| ▸ | PPARG | P37231 | 1/20 | 0.45 |
| ▸ | PPARA | Q07869 | 1/20 | 0.45 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13110443 | 0.94 | FFAR1 (0.50) | FFAR1PPARD | |
| SCHEMBL3451391 | 0.93 | FFAR1 (0.57) | FFAR1PPARDPPARGPPARA | |
| SCHEMBL3451532 | 0.88 | FFAR1 (0.58) | FFAR1PPARD | |
| SCHEMBL3917024 | 0.81 | NPSR1 (0.53) | FFAR1PPARD | |
| SCHEMBL3911602 | 0.80 | NPSR1 (0.51) | FFAR1PPARD | |
| SCHEMBL13110508 | 0.79 | FFAR1 (0.61) | FFAR1PPARDPPARGPPARA | |
| SCHEMBL3450254 | 0.76 | FFAR1 (0.61) | FFAR1PPARDPPARGPPARA | |
| SCHEMBL1745481 | 0.76 | NPSR1 (0.47) | FFAR1PPARD | |
| SCHEMBL3912223 | 0.76 | PPARD (0.57) | FFAR1PPARDPPARGPPARA | |
| SCHEMBL13110490 | 0.76 | FFAR1 (0.85) | FFAR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7820837-B2 | ethyl {6-[(3-phenoxybenzyl)oxy]-3,4-dihydronaphthalen-1-yl}acetate; having a GPR40 receptor function modulating action and being useful as an insulin secretagogue or a pharmaceutical agent for the prophylaxis or treatment of diabetes | TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) | 2010-10-26 | — | — | US | disclosed |
| US-7820837-B2 | ethyl {6-[(3-phenoxybenzyl)oxy]-3,4-dihydronaphthalen-1-yl}acetate; having a GPR40 receptor function modulating action and being useful as an insulin secretagogue or a pharmaceutical agent for the prophylaxis or treatment of diabetes | TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) | 2010-10-26 | — | — | US | disclosed |